Evidence map›Paper›PMID 32917959›Full record

ReviewExperimental & molecular medicine2020

Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases.

Doo Sin Jo, Na Yeon Park, Dong-Hyung Cho

Open access · goldAbstract readReview
In one paragraph

Review in Experimental & molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Polyunsaturated fatty acid metabolism in the retinal pigment epithelium and its association with outer retinal disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Doo Sin Jo *Brain Science and Engineering Institute, Kyungpook National University, Daegu, 41566, Republic of Korea.
Na Yeon Park *School of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
Dong-Hyung ChoBrain Science and Engineering Institute, Kyungpook National University, Daegu, 41566, Republic of Korea. dhcho@knu.ac.kr.
Kyungpook National University · KR

Funding

Ministry of Education (Ministry of Education of the Republic of Korea) 2020R1I1A1A01073696National Research Foundation of Korea (NRF) 2020R1A2C2003523
6 · The paper itself

Abstract

In recent decades, the role of the peroxisome in physiology and disease conditions has become increasingly important. Together with the mitochondria and other cellular organelles, peroxisomes support key metabolic platforms for the oxidation of various fatty acids and regulate redox conditions. In addition, peroxisomes contribute to the biosynthesis of essential lipid molecules, such as bile acid, cholesterol, docosahexaenoic acid, and plasmalogen. Therefore, the quality control mechanisms that regulate peroxisome biogenesis and degradation are important for cellular homeostasis. Current evidence indicates that peroxisomal function is often reduced or dysregulated in various human disease conditions, such as neurodegenerative diseases. Here, we review the recent progress that has been made toward understanding the quality control systems that regulate peroxisomes and their pathological implications.

Indexed as

Lipid MetabolismAnimalsBiomarkersDisease SusceptibilityEndoplasmic ReticulumHomeostasisHumansMetabolic Networks and PathwaysNeurodegenerative DiseasesOxidation-ReductionPeroxisomesProtein Processing, Post-TranslationalBiomarkers

Identifiers

PMID32917959
PMCPMC8080768
OpenAlexW3084148404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.